Caroline Krumel

2012

In 2012, Caroline Krumel earned a total compensation of $547.4K as Former Vice President of Finance and Principal Accounting Officer at PDL BioPharma, a 51% increase compared to previous year.

Compensation breakdown

Bonus$80,400
Non-Equity Incentive Plan$147,756
Salary$237,000
Stock Awards$30,200
Other$52,000
Total$547,356

Krumel received $237K in salary, accounting for 43% of the total pay in 2012.

Krumel also received $80.4K in bonus, $147.8K in non-equity incentive plan, $30.2K in stock awards and $52K in other compensation.

Rankings

In 2012, Caroline Krumel's compensation ranked 8,455th out of 11,487 executives tracked by ExecPay. In other words, Krumel earned more than 26.4% of executives.

ClassificationRankingPercentile
All
8,455
out of 11,487
26th
Division
Manufacturing
3,070
out of 4,253
28th
Major group
Chemicals And Allied Products
817
out of 1,198
32nd
Industry group
Drugs
592
out of 920
36th
Industry
Biological Products, Except Diagnostic Substances
97
out of 160
39th
Source: SEC filing on April 17, 2014.

Krumel's colleagues

We found four more compensation records of executives who worked with Caroline Krumel at PDL BioPharma in 2012.

2012

John McLaughlin

PDL BioPharma

Chief Executive Officer

2012

Christopher Stone

PDL BioPharma

General Counsel

2012

Danny Hart

PDL BioPharma

Vice President, Business Development

2012

Bruce Tomlinson

PDL BioPharma

Chief Financial Officer

You may also like